A phase IIa, double-blinded, randomized trial comparing the pharmacokinetics, pharmacodynamics and safety of BioChaperone rhInsulin to fast-acting insulin analog in patients with Type 1 Diabetes mellitus.

Trial Profile

A phase IIa, double-blinded, randomized trial comparing the pharmacokinetics, pharmacodynamics and safety of BioChaperone rhInsulin to fast-acting insulin analog in patients with Type 1 Diabetes mellitus.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Mar 2013

At a glance

  • Drugs Insulin (Primary) ; Insulin aspart (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 28 Feb 2012 Status changed from recruiting to completed, according to an Adocia media release.
    • 20 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top